David Martin Colquhoun

ORCID：0000-0002-4263-017X

发表论文 499 篇 · 总被引 26010 次 · h-index 80

代表论文

• Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial (2021 · The Lancet · 被引 669)
• The reproducibility of research and the misinterpretation of p -values (2017 · Royal Society Open Science · 被引 262)
• Five ways to fix statistics (2017 · Nature · 被引 104)
• Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes (2023 · Annals of Internal Medicine · 被引 102)
• Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia (2020 · Heart Lung and Circulation · 被引 99)
• Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial (2018 · The Lancet · 被引 94)